Safety and Efficacy of Positron Emission Tomography Imaging With MNI-513
Stopped early · Early Phase 1
Conditions studied: Alzheimer Disease
In brief
The purpose of the study is to evaluate the efficacy and safety of MNI-513 positron emission tomography (PET) for detection/exclusion of cerebral amyloid beta in patients with Alzheimer's disease compared to healthy volunteers.
Key facts
- Study ID
- NCT01000870
- Run by
- Institute for Neurodegenerative Disorders
- People needed
- 6
- Starts
- 2009-10-01
- Expected to finish
- 2010-09-01
- Last updated by the study team
- 2010-10-06
Who can join
Age: 55 and older. Sex: any. Healthy volunteers: accepted.
Where it is running
- Institute for Neurodegenerative Disorders — New Haven, Connecticut, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.